Resources / Medication education
Atypical antipsychotics: badly named, broadly used
The name suggests they're only for psychosis. In practice, second generation antipsychotics, aripiprazole, quetiapine, olanzapine, risperidone, lurasidone and others, treat schizophrenia, bipolar disorder, and stubborn depression, and the honest conversation about them is mostly about metabolic trade-offs and monitoring.
Medically reviewed by Shariq Refai, MD, MBA, FAPA, board certified psychiatrist · Published June 7, 2026 · Last reviewed June 8, 2026 · Editorial policy
What they treat
Far beyond psychosis
Evidence supported uses include:
- Schizophrenia and schizoaffective disorder, their core indication
- Acute mania and bipolar maintenance
- Bipolar depression (lurasidone and quetiapine carry specific approvals)
- Augmenting antidepressants in resistant unipolar depression (aripiprazole is the classic)
- Severe agitation and certain other targeted uses
How they differ
A family with very different personalities
All modulate dopamine and serotonin signaling, but their day-to-day personalities diverge sharply. Aripiprazole tends activating and weight-light; quetiapine sedating, useful when sleep is wrecked, with more metabolic load; olanzapine highly effective and the heaviest metabolically; risperidone effective with dose-related hormonal effects; lurasidone comparatively weight-friendly with bipolar-depression strength. Choosing among them is matching profiles to your life, not picking 'the strongest.'
The honest cost
Metabolic effects and the monitoring that answers them
The class can increase weight, blood sugar, and lipids, more for some agents than others, and responsible prescribing means measuring, not hoping: baseline and periodic weight, glucose or A1c, and lipids. Movement-related side effects (restlessness, stiffness, and with long exposure, tardive dyskinesia) are watched at every visit; caught early, they're manageable. None of this is fine print at shrinkMD; it's said before the first dose, because informed patients do better.
Keep exploring
Related reading
Frequently asked questions
Good questions, clear answers
Why would an antipsychotic be used for my depression?
At low doses, certain atypicals reliably boost a partially working antidepressant, with FDA approval for exactly that. The name is historical; the use is evidence based.
Will I gain weight?
It depends heavily on the agent: olanzapine and quetiapine carry the most risk, aripiprazole and lurasidone the least. We choose with that in view and measure rather than guess.
What is tardive dyskinesia?
Involuntary movements that can emerge after long exposure, the reason movement checks happen at every visit. Risk rises with time and dose; early detection changes the plan early.
Are these sedating?
Quetiapine and olanzapine commonly are; aripiprazole often the opposite. Sedation is a selection criterion, sometimes even a feature, not a surprise.
Do I need blood tests on these?
Periodic metabolic labs, yes: glucose or A1c and lipids, plus weight tracking. It's the monitoring that keeps a powerful class honest.
Are atypical antipsychotics addictive?
No, they are not controlled substances and produce no cravings or tolerance-driven escalation. Stopping abruptly can still destabilize the condition being treated, so changes are planned, not improvised.
How long would I take one as an antidepressant booster?
Typically reviewed within months, not assumed permanent: once remission consolidates, we test whether the augmentation is still earning its metabolic cost. That review is scheduled, not forgotten.
Will an atypical help me sleep?
The sedating members often do, sometimes usefully, sometimes excessively. Sedation is part of the selection conversation up front, never a surprise you discover at work the next morning.
Questions about medication? That's what evaluations are for
Meet a board certified clinician by video, as clinician availability allows, and get answers specific to you. We prescribe responsibly and never prescribe controlled substances.
Join Our Waiting List